Innovation is steadily entering the global marketplace.
The medical technology industry is in demand and constantly evolving.
Against the backdrop of growing demand, blood glucose meters (CGMs) are being upgraded to become increasingly essential for a wide range of people.
When analyzing the performance of companies producing CGM devices, we see a steady growth in sales and, as a consequence, a high growth in capitalization of these companies.
Based on this data, we project the capitalization of MLC Engineering to grow to $ 20 billion, but even that is not the limit.
The share price at the current stage and the projected price after the project implementation will increase 1,000 times in the future.
Holders of the company's shares can also benefit from the dividends, which will be paid out based on 50% of the company's revenue.
The niche of CGM devices is underdeveloped, the competition is low and the growth potential is high.
Our goal is to make blood glucose meters more accessible in every part of the world, and thus improve the quality of life and longevity for many people.
Join the MLC Engineering project by registering at MLC.health!
By uniting our efforts we will reach our goals faster and help each other!
